AstraZeneca has opened its first U.S.-operated cell therapy manufacturing facility in Rockville, Maryland, as part of its ...

A federal appeals court on Thursday shut down AstraZeneca’s challenge to the U.S. government’s program that gives the ...

AstraZeneca opens a $300 million cell therapy manufacturing facility in Rockville, boosting the local biotech industry.

The facility, which will produce cell therapies used to treat cancer and auto immune diseases, creates 150 jobs for highly ...

As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the ...

The company noted that no new safety concerns were identified with the combination of Imfinzi and BCG induction and ...

British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the ...

The company removed experimental drugs for Alzheimer’s, migraine and pain from its pipeline to focus more resources on “core ...

The drugmaker posted increased core earnings per share and sales for the first quarter, but also said it could face a fine of ...

Investors in AstraZeneca plc (Symbol: AZN) saw new options become available today, for the June 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AZN ...

The biggest strategic highlight for Tempus AI Inc. (NASDAQ: TEM) during the first quarter was a multi-million dollar deal to build "the world's largest foundation model for oncology." ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...